The Lancet Oncology
LightNews LightNews
banner
thelancetoncol.bsky.social
The Lancet Oncology
@thelancetoncol.bsky.social
930 followers 47 following 120 posts
The Lancet Oncology is the global leader in clinical oncology publishing peer-reviewed research and reviews, comment, news, and Commissions. IF=35·9.

🌐 https://www.thelancet.com/journals/lanonc/home
Posts Replies Media Videos
thelancetoncol.bsky.social
✏️This month's Editorial: Making prostate cancer screening fit for purpose

www.thelancet.com/journals/lan...
November 25, 2025 at 12:24 PM
thelancetoncol.bsky.social
🚨Our Dec issue is live! - thelancet.com/issue/S1470-...

📊Articles: #lungcancer, #breastcancer, #hepatocellularcarcinoma, #rectalcancer, #glioma

📑Reviews including neurocognitive outcomes in patients with brain metastases AND SISAQOL-IMI consensus guidelines on PROs in trials
November 25, 2025 at 9:58 AM
thelancetoncol.bsky.social
🔴Online: Artificial intelligence and radiologists in #pancreaticcancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational study

thelancet.com/journals/lan...
November 21, 2025 at 1:46 PM
thelancetoncol.bsky.social
Check out London Global Cancer Week #LGCW2025, running Nov 24 to Nov 28.

www.lgcw.org.uk/lgcw-2025/

It's a pleasure for @thelancetoncol.bsky.social to sponsor another year!
November 18, 2025 at 3:45 PM
thelancetoncol.bsky.social
📊Online now: Effectiveness of NELSON versus PLCOm2012 #lungcancer screening eligibility criteria in Germany (HANSE): a prospective cohort study
thelancet.com/journals/lan...

✏️Comment: Defining eligibility for lung cancer screening based on individual risk
thelancet.com/journals/lan...
November 12, 2025 at 1:28 PM
thelancetoncol.bsky.social
✏️Our Editorial - International funding for cancer care: a shared responsibility

thelancet.com/journals/lan...

🎧Listen to our podcast: Deputy Editor Ali Landman speaks with Matthias Preusser on the phase 2 TUXEDO-3 trial in patients with brain metastases

thelancet.com/multimedia/p...
October 28, 2025 at 10:46 AM
thelancetoncol.bsky.social
🚨Our Nov issue is live - thelancet.com/issue/S1470-...

📊Articles: #breastcancer, #NSCLC, #prostatecancer, #melanoma

📰 Reviews: Tumour-infiltrating lymphocyte therapy in the era of genetic engineering AND AI for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO)
October 28, 2025 at 9:39 AM
thelancetoncol.bsky.social
🆕Online: Overall survival assessment in cancer drug trials: a luxury or a necessity?

Samuel X Stevens, @lateuwen.bsky.social, and Bishal Gyawali discuss the #FDA draft guidance on overall survival in randomised cancer drug trials

thelancet.com/journals/lan...
October 17, 2025 at 12:41 PM
thelancetoncol.bsky.social
🚨Our Oct issue is live -
thelancet.com/issue/S1470-...

📈Articles: on #RCC, #SCLC, #NSCLC, #BladderCancer, #Myeloma, #PancreaticCancer,
#EndometrialCancer, and #ThyroidCancer

📝Reviews: EU–CAYAS–NET recommendations for health-care transitions in young people beyond
childhood cancer
September 30, 2025 at 8:41 AM
thelancetoncol.bsky.social
🚨Our Sept issue is live - 25 years! thelancet.com/journals/lan...

📊Articles #renalcellcarcinoma, #prostatecancer, #meningioma, #thymiccarcinoma, & #colorectalcancer

Reviews: 📰 ESTRO and ASTRO plus endorsed guidelines on vol delineation & 📰 Common Sense Oncology and EORTC on reporting QoL data
September 12, 2025 at 8:23 AM
thelancetoncol.bsky.social
Super session announcing a new @thelancet.com @iaslc.bsky.social Commission on lung cancer at this year’s WCLC 2025 in Barcelona
September 7, 2025 at 9:45 AM
thelancetoncol.bsky.social
🔴Online today: Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic #colorectalcancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial

thelancet.com/journals/lan...
August 12, 2025 at 3:41 PM
thelancetoncol.bsky.social
🚨Online today: Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant #prostatecancer in #ENZAp (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial

www.thelancet.com/journals/lan...
August 1, 2025 at 8:17 AM
thelancetoncol.bsky.social
At clinical examination, the patient showed no neurological deficits. On the frontal part of his head, he had a wound from which a fluid was visibly pulsating. A CT of the brain was done and showed extensive pneumocephalus, with breakthrough osteolysis on the frontal left cranium
July 30, 2025 at 3:55 PM
thelancetoncol.bsky.social
✏️Our editorial discusses the advantages and pitfalls of computer-aided drug design platforms and AI

Cancer drug discovery at warp speed: can AI deliver?

thelancet.com/journals/lan...
July 29, 2025 at 4:33 PM
thelancetoncol.bsky.social
🎧In our Aug podcast, author, Dr Jinming Li, discusses patterns in genomic mutations among patients with early-onset #colorectalcancer with Editor, Dr Cheryl Reeves

thelancet.com/multimedia/p...

📰 Article thelancet.com/journals/lan...
July 29, 2025 at 1:43 PM
thelancetoncol.bsky.social
📢Our Aug issue is now live: thelancet.com/issue/S1470-...

📊Original research #prostatecancer, contraceptive use and #livercancer, #rectalcancer, #colorectalcancer, #myeloma, #hodgkinlymphoma, paediatric NS tumours, and #breastcancer

📖Reviews #endometrialcancer management and PET imaging
July 29, 2025 at 9:04 AM
thelancetoncol.bsky.social
🔴Online now: HER2DX and survival outcomes in early-stage HER2-positive #breastcancer: an individual patient-level meta-analysis

www.thelancet.com/journals/lan...
July 15, 2025 at 8:26 AM
thelancetoncol.bsky.social
Online: Metformin for patients with metastatic #prostatecancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol

@cancerresearchuk.org, @mrcctu.bsky.social

www.thelancet.com/journals/lan...
July 8, 2025 at 11:09 AM
thelancetoncol.bsky.social
Online first: Oral contraceptive use and risk of #livercancer: a population-based study, systematic review, and meta-analysis

thelancet.com/journals/lan...

Linked comment: Oral contraceptives and risk of liver cancer

thelancet.com/journals/lan...
July 4, 2025 at 11:16 AM
thelancetoncol.bsky.social
Are you ready for your research to spark global conversation? ✨ Begin your publication journey with us today and help to advance health and science worldwide.

hubs.li/Q03vpxN70
July 3, 2025 at 2:56 PM
thelancetoncol.bsky.social
Congratulations to our authors and peer reviewers, whose expertise and hard work enable us to continuously publish some of the best science for better lives. This is as much your achievement!
July 3, 2025 at 2:54 PM
thelancetoncol.bsky.social
July Editorial: Politics and pharma—hurdles in UK science ambitions

🔬In June, the UK government announced plans to boost science and technology research and development; however, a stand-off with the pharmaceutical industry over profits threatens these plans

www.thelancet.com/journals/lan...
July 2, 2025 at 1:25 PM
thelancetoncol.bsky.social
July issue: Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study

www.thelancet.com/journals/lan...
July 1, 2025 at 10:08 AM
thelancetoncol.bsky.social
July issue: Hormone therapy use and young-onset #breastcancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group

🖱️ www.thelancet.com/journals/lan...
July 1, 2025 at 8:44 AM